206 related articles for article (PubMed ID: 7681523)
1. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643.
Hwang JJ; Hsia MT; Jirtle RL
Mutat Res; 1993 Apr; 286(2):123-33. PubMed ID: 7681523
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
4. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
6. Chromosome aberrations, micronuclei and sister-chromatid exchanges (SCEs) in rat liver induced in vivo by hepatocarcinogens including heterocyclic amines.
Sawada S; Yamanaka T; Yamatsu K; Furihata C; Matsushima T
Mutat Res; 1991 Nov; 251(1):59-69. PubMed ID: 1944376
[TBL] [Abstract][Full Text] [Related]
7. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
[TBL] [Abstract][Full Text] [Related]
8. WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes.
Rusyn I; Tsukamoto H; Thurman RG
Carcinogenesis; 1998 Jul; 19(7):1217-22. PubMed ID: 9683180
[TBL] [Abstract][Full Text] [Related]
9. Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures.
Karam WG; Ghanayem BI
Carcinogenesis; 1997 Nov; 18(11):2077-83. PubMed ID: 9395205
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
Hayashi F; Tamura H; Yamada J; Kasai H; Suga T
Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
12. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
13. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.
Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1991 Mar; 12(3):469-73. PubMed ID: 1849052
[TBL] [Abstract][Full Text] [Related]
14. Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment.
Cattley RC; Smith-Oliver T; Butterworth BE; Popp JA
Carcinogenesis; 1988 Jul; 9(7):1179-83. PubMed ID: 3383337
[TBL] [Abstract][Full Text] [Related]
15. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
Wada N; Marsman DS; Popp JA
Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
[TBL] [Abstract][Full Text] [Related]
16. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells.
Tsutsui T; Watanabe E; Barrett JC
Carcinogenesis; 1993 Apr; 14(4):611-8. PubMed ID: 8472324
[TBL] [Abstract][Full Text] [Related]
17. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators.
Rose ML; Germolec DR; Schoonhoven R; Thurman RG
Carcinogenesis; 1997 Aug; 18(8):1453-6. PubMed ID: 9276615
[TBL] [Abstract][Full Text] [Related]
18. Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectable foci in rat liver.
Cattley RC; Marsman DS; Popp JA
Toxicology; 1989 May; 56(1):1-7. PubMed ID: 2728002
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.
Bojes HK; Germolec DR; Simeonova P; Bruccoleri A; Schoonhoven R; Luster MI; Thurman RG
Carcinogenesis; 1997 Apr; 18(4):669-74. PubMed ID: 9111198
[TBL] [Abstract][Full Text] [Related]
20. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
